Kueppers F, Bromke B J
J Lab Clin Med. 1983 May;101(5):747-57.
The isolation and characterization of three protease inhibitors from tracheobronchial secretions are described. As starting material, pooled secretions from patients with tracheostomies was used. The isolation procedure consisted of precipitation with 3% perchloric acid (the major acid-stable inhibitors remain in solution), affinity chromatography on trypsin-Sepharose, and preparative zone electrophoresis. We found three distinct inhibitors. One was a basic protein with evidence of size and charge heterogeneity but immunologic homogeneity, Mr = 15,850 +/- 1200 daltons, 12,600 +/- 700, 6500 +/- 500. Two inhibitors were acidic proteins, Mr = 63,400 +/- 3200 (AI) and 19,960 +/- 1500 (AII) daltons. The basic inhibitor had tyrosine as the sole aminoterminal amino acid. For the two acidic inhibitors, an aminoterminus was not found. All three inhibitors contained neutral sugars and amino sugars but no sialic acid. They inhibit trypsin, chymotrypsin, and human granulocytic elastase. The two acidic inhibitors are immunologically related; they are apparently derived from serum ITI. Inhibitor AII originates from inhibitor AI, probably by limited proteolysis by several proteases. The concentration of the basic inhibitor in bronchial secretions of 42 patients with obstructive lung disease was 0.206 +/- 0.15 mg/ml.
本文描述了从气管支气管分泌物中分离和鉴定三种蛋白酶抑制剂的过程。起始材料为气管切开患者的混合分泌物。分离步骤包括用3%的高氯酸沉淀(主要的酸稳定抑制剂保留在溶液中)、在胰蛋白酶-琼脂糖上进行亲和层析以及制备区带电泳。我们发现了三种不同的抑制剂。一种是碱性蛋白,具有大小和电荷异质性但免疫同质性的证据,Mr = 15,850 ± 1200道尔顿、12,600 ± 700、6500 ± 500。两种抑制剂是酸性蛋白,Mr分别为63,400 ± 3200(AI)和19,960 ± 1500(AII)道尔顿。碱性抑制剂以酪氨酸作为唯一的氨基末端氨基酸。对于两种酸性抑制剂,未发现氨基末端。所有三种抑制剂都含有中性糖和氨基糖,但不含唾液酸。它们抑制胰蛋白酶、糜蛋白酶和人粒细胞弹性蛋白酶。两种酸性抑制剂在免疫上相关;它们显然源自血清ITI。抑制剂AII可能是由几种蛋白酶进行有限的蛋白水解作用从抑制剂AI衍生而来。42例阻塞性肺病患者支气管分泌物中碱性抑制剂的浓度为0.206 ± 0.15 mg/ml。